Trial Profile
Mechanism of action and metabolic effects of exenatide in obesity
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Oct 2016
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Obesity
- Focus Pharmacodynamics
- 16 Sep 2016 Results assessing the effect of exenatide on glucose disposal, beta cell function and incretin hormones in non-diabetic obese subjects, presented at the 52nd Annual Meeting of the European Association for the Study of Diabetes.
- 25 Jun 2013 Status changed from recruiting to completed, according to presentation of results at the 73rd Annual Scientific Sessions of the American Diabetes Association.
- 25 Jun 2013 Results presented at the 73rd Annual Scientific Sessions of the American Diabetes Association.